Back

Myocardial fibrosis predicts sudden cardiac death in patients with hypertrophic cardiomyopathy after cardiac electronic device implantation: a retrospective study

29 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Risk prediction and management of ventricular arrhythmias in non-ischaemic cardiomyopathies Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Xinqiao Lian

Beijing (China)

6 More presentations in this session

Presentation thumbnail
Gene-specific risk models in genetic dilated cardiomyopathy for implantable cardioverter defibrillator decisions: a critical perspective on limitations and applicability
Doctor A. Beblo (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Late gadolinium enhancement and ventricular arrhythmias in patients with dilated cardiomyopathy: a systematic review and meta-analysis
Ms S. Mahmud (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Cohort analysis of variants in the RBM20 gene. Is there a profile for electrocardiographic phenotype, arrhythmogenic features and outcomes?
Doctor M. Pagotti (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Genetic defects in young out-of-hospital cardiac arrest (OHCA) patients in our city: the GenetiCA study
Doctor E. Baldi (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Myocarditis complicated by ventricular tachycardia: prevalence, outcomes and acute ablation results
Associate Professor E. Leshem (Hadera, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk prediction and management of ventricular arrhythmias in non-ischaemic cardiomyopathies

The Event

Event poster

ESC Congress 2025

29 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging: pro
thumbnail
Congress Session
Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging
thumbnail
Congress Presentation
Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines - LGE remains tough to beat

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources